Cargando…
Direct inhibition of dioxygenases TET1 by the rheumatoid arthritis drug auranofin selectively induces cancer cell death in T-ALL
T-cell acute lymphoblastic leukemia (T-ALL) is a type of hematologic tumor with malignant proliferation of hematopoietic progenitor cells. However, traditional clinical treatment of T-ALL included chemotherapy and stem cell transplantation always lead to recurrence and poor prognosis, thus new thera...
Autores principales: | Chen, Long, Ren, Anqi, Zhao, Yuan, Chen, Hangyu, Wu, Qifang, Zheng, Mengzhu, Zhang, Zijian, Zhang, Tongcun, Zhong, Wu, Lin, Jian, Zhu, Haichuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666452/ https://www.ncbi.nlm.nih.gov/pubmed/37993905 http://dx.doi.org/10.1186/s13045-023-01513-6 |
Ejemplares similares
-
Role of DNA dioxygenase Ten-Eleven translocation 3 (TET3) in rheumatoid arthritis progression
por: Kawabe, Akio, et al.
Publicado: (2022) -
CAR T-Cell Immunotherapy Treating T-ALL: Challenges and Opportunities
por: Ren, Anqi, et al.
Publicado: (2023) -
Decoding the role of TET family dioxygenases in lineage specification
por: Wu, Xinwei, et al.
Publicado: (2018) -
Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma
por: Wang, Jeffrey, et al.
Publicado: (2019) -
Role of TET dioxygenases in the regulation of both normal and pathological hematopoiesis
por: Joshi, Kanak, et al.
Publicado: (2022)